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Background: Pelgipeptin, a potent antibacterial and antifungal agent, is a non-ribosomally synthesised lipopeptide
antibiotic. This compound consists of a β-hydroxy fatty acid and nine amino acids. To date, there is no information
about its biosynthetic pathway.
Results: A potential pelgipeptin synthetase gene cluster (plp) was identified from Paenibacillus elgii B69 through
genome analysis. The gene cluster spans 40.8 kb with eight open reading frames. Among the genes in this cluster,
three large genes, plpD, plpE, and plpF, were shown to encode non-ribosomal peptide synthetases (NRPSs), with one,
seven, and one module(s), respectively. Bioinformatic analysis of the substrate specificity of all nine adenylation
domains indicated that the sequence of the NRPS modules is well collinear with the order of amino acids in
pelgipeptin. Additional biochemical analysis of four recombinant adenylation domains (PlpD A1, PlpE A1, PlpE A3,
and PlpF A1) provided further evidence that the plp gene cluster involved in pelgipeptin biosynthesis.
Conclusions: In this study, a gene cluster (plp) responsible for the biosynthesis of pelgipeptin was identified from the
genome sequence of Paenibacillus elgii B69. The identification of the plp gene cluster provides an opportunity to
develop novel lipopeptide antibiotics by genetic engineering.
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The intensive use of chemical pesticides to treat plant
diseases has resulted in various problems such as severe
environmental pollution, food safety concerns, and
emergence of drug resistance. Biological control using
microorganisms or their metabolites, a more rational
and safer method, has emerged as a promising alterna-
tive to suppress plant pathogens and reduce the use of
agrochemicals [1,2]. Pelgipeptins, a group of natural ac-
tive compounds isolated from Paenibacillus elgii B69,
are potential biological control agents [1]. This group of
antibiotics has a general structure composed of a cyclic
nonapeptide moiety and a β-hydroxy fatty acid. Four* Correspondence: mblab@zju.edu.cn
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reproduction in any medium, provided the oranalogues of pelgipeptin have been identified and char-
acterised [3]. These analogues are highly similar in
structure and differ only in one amino acid unit or in
the lipid acid (Figure 1A). Pelgipeptin exhibits broad-
spectrum antimicrobial activity against pathogenic
bacteria and fungi, including Staphylococcus aureus, En-
terococcus faecalis, Escherichia coli, Candida albicans,
Fusarium oxysporum, F. graminearum, F. moniliforme,
Rhizoctonia solani, and Colletotrichum lini [1,3]. This
compound effectively inhibited the development of
sheath blight caused by R. solani on rice in a preliminary
evaluation of the in vivo efficacy of pelgipeptin [1].
Similar to polymyxin and fusaricidin from P. poly-
myxa, pelgipeptin, containing non-proteinogenic and D-
amino acids, must be synthesised by a non-ribosomal
peptide synthetase (NRPS). NRPS is a large multifunc-
tional enzyme that has modular structures [4]. Eachd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Pelgipeptin and the genes responsible for its biosynthesis. (A) Primary structure of pelgipeptin. (B) The plp gene cluster and
domain organisation of the NRPS.
Qian et al. BMC Microbiology 2012, 12:197 Page 2 of 7
http://www.biomedcentral.com/1471-2180/12/197NRPS module catalyses the incorporation of a specific
substrate into the growing product. A typical module
consists of three enzymatic domains, namely, adenyla-
tion (A), thiolation (T; also known as peptidyl carrier
protein), and condensation (C) domains. The A domain
selects and activates a specific amino acid substrate, the
T domain is responsible for tethering the activated sub-
strate to the 40-phosphopanthetheinyl cofactor, and the
C domain catalyses peptide bond formation between the
elongating peptide and a new amino acid. In addition to
these core domains, the terminal thioesterase (TE) and
epimerisation (E) domains, as well as several other tai-
loring domains, may also be present in NRPS modules.
The order of modules of an NRPS is, in many cases, col-
linear to the amino acid sequence of the corresponding
peptide product. The collinearity rule of NRPS systems
combined with knowledge of the specificity-conferring
code of A domain allow for the prediction and amino
acid modification of peptide fragments synthesised by
corresponding NRPS [5]. However, few NRPS sequences
have been extensively described in comparison with the
number of known peptide products, limiting the studyof the principles of non-ribosomal peptide synthesis and
the development of new bioactive peptides by genetic
engineering. In this study, we identified and analysed a
gene cluster involved in the biosynthesis of pelgipeptin
and provided biochemical data for the collinearity of this
peptide assembly line.
Methods
Bacteria strains and culture conditions
P. elgii B69, isolated from a soil sample [1], was cultured
in nutrient broth. E. coli DH5α, for gene manipulation,
and E. coli BL21 (DE3), for overexpression of recombin-
ant proteins, were cultivated on Luria-Bertani medium.
Identification and in silico analysis of plp gene cluster in
P. elgii B69
The draft genome sequence of the strain was used to
build a database in Bioedit to identify the putative NRPS
genes in P. elgii B69 (http://www.mbio.ncsu.edu/BioEdit/
bioedit.html). The first and second C domains of PmxE
(GenBank EU371992), which is a polymyxin synthetase
subunit, were compared with the created database using
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Amino acid sequence homology searches were per-
formed using the BLAST server at the National Centre
for Biotechnology Information (NCBI, http://www.ncbi.
nlm.nih.gov/BLAST/) site. NRPS domains were identi-
fied by PKS/NRPS analysis (http://nrps.igs.umaryland.
edu/nrps/) [7]. Prediction of 10 amino acids located at
the substrate-binding pocket of the A domain and sub-
strate specificity prediction were performed using the
web-based program NRPS predictor (http://ab.inf.uni-
tuebingen.de/software/NRPSpredictor/) [8].Cloning, expression and purification of A domains
We synthesised four sets of specific forward and reverse
primers: plpD-A1-F (CTAGCCATGGAAAACATTTTG-
ACCCG) and plpD-A1-R (CACCTCGAGTTCG-
TACTCCGCTCCG); plpE-A1-F (GACACCATGGATT-
TGTTGTCGGAAG) and plpE-A1-R (ATCCTCGAGC-





amplify the A domains of PlpD A1, PlpE A1, PlpE A3,
and PlpF A1. The genes encoding these A domains were
PCR-amplified from the genomic DNA of P. elgii B69
and cloned into pET28a vector. The recombinant plas-
mid was transformed into E. coli DH5α for gene manipu-
lation. After transformation into E. coli BL21 (DE3), the
recombinant proteins were overexpressed and produced
as described previously [9].
BL21 strains expressing each A domain were grown
in Luria–Bertani medium supplemented with 50 μg/ml
kanamycin at 37 °C until its OD600 reached about 0.5.
Gene expression was induced by 0.1 mM isopropyl-b-D-
thiogalactopyranoside at 30 °C for 4 h. Cells were har-
vested by centrifugation, resuspended in buffer A (40 mM
Tris–HCl, 200 mM NaCl, 20 mM imidazole, pH 8.0), and
lysed by sonication on ice. The lysates were centrifuged at
12 000 g for 30 min at 4 °C, and the supernatants were
loaded onto a Ni Sepharose 6 FF (GE Healthcare) column.
The column was washed with five bed volumes of buffer
A, followed by five bed volumes of buffer B (40 mM Tris–
HCl, 200 mM NaCl, 60 mM imidazole, pH 8.0). The re-
combinant proteins were then eluted by buffer C (40 mM
Tris–HCl, 200 mM NaCl, 150 mM imidazole, pH 8.0).
Purified proteins were detected by 10 % sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and dialysed against buffer D (40 mM Tris–HCl, pH 8.0,
200 mM NaCl, and 1 mM dithiothreitol). Protein concen-
tration was determined by the bicinchoninic acid protein
assay (Pierce, USA) using bovine serum albumin as the
standard.Determination of substrate specificity
The substrate selectivity of each of the A domains was
determined using a non-radioactive assay [10]. The re-
action mixture (40 μl) contained 0.5 μM recombinant
A domain, 0.2 U/ml inorganic pyrophosphatase, 5 mM
ATP, 100 mM NaCl, 10 mM MgCl2, and 6 mM amino
acid in 50 mM Tris–HCl (pH 7.5). Reactions were
started by the addition of ATP and incubated at 25 °C.
The reactions were terminated by the addition of mo-
lybdate/malachite green reagent. After 15 min of colour
development, optical density was measured at 600 nm
on a microplate reader (Multiscan MK3, Thermo Elec-
tron Co. Ltd., Shanghai, China). A reaction mixture
lacking the recombinant A domain was used as a nega-
tive control.
Nucleotide sequence accession numbers
The DNA sequences for the pelgipeptin biosynthetic
gene cluster in P. elgii B69 was deposited in the Gen-
Bank under accession number JQ745271.
Results and discussion
Analysis of the organisation of the plp gene cluster and
its flanking regions
We recently completed the draft genome sequence of
the pelgipeptin-producing bacterium P. elgii B69, in
which at least 5 NRPS-related biosynthetic gene clusters
were found within its 7,981,270 bp long scaffold [11].
Further inspection revealed that several NRPS genes
located in scaffolds 3 and 43 were probably related with
pelgipeptin biosynthesis. The gaps between and within
these two scaffolds were filled by sequencing PCR pro-
ducts. These efforts resulted in a complete NRPS gene
cluster (plp), harbouring eight open reading frames
(ORFs), which could be assigned to pelgipeptin biosyn-
thesis. These ORFs (designated plpA-plpH) were tran-
scribed in the same direction (Figure 1B). Upstream of
the plp locus, two genes (ORF2 and ORF3) encoding
proteins with similarities to heparinase II/III family pro-
teins (YP_003243728 and YP_003243727, respectively)
were transcribed in the same direction and were consid-
ered not to be involved in pelgipeptin production. Fur-
ther upstream, a third ORF (ORF1), with TGA stop
codon within ORF2, was found to encode a protein with
high similarity to short-chain dehydrogenases/reductases
(ZP_08509633) and was also considered not involved in
the pelgipeptin biosynthesis. Downstream of the plpF
gene, four genes encoding putative ABC transporter pro-
teins were found. PlpG and PlpH, shared 72% and 69%
identities with PmxC and PmxD, respectively, which
were considered responsible for the secretion of poly-
myxin produced by P. polymyxa [12]. This transport ac-
tivity may be needed for the transport of pelgipeptin out
of the cell, and therefore, the gene products were
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genes (ORF4 and ORF5) encoding putative nitrate/
sulphonate/bicarbonate ABC transporter proteins were
transcribed in the opposite direction and were consid-
ered less likely to be involved in pelgipeptin production,
although further evidence will be required before this
can be decided unequivocally. The putative ORFs and
the genetic organisation of the chromosomal region con-
taining these sequences are depicted in Figure 1B.Genes encoding NRPS
As shown in Figure 1B, three NRPS genes, plpD, plpE, and
plpF, are present in the plp cluster, and these genes encode
proteins with estimated molecular masses of 171.8, 951.3,
and 122.9 kDa, respectively. The modules and domains of
pelgipeptin synthetase were analysed as described in the
“Materials and methods” section above. PlpD, containing
four domains (C-A-T-C) (Figure 1B), had an N-terminal C
domain, which shared 43% identity with the starter C do-
main of PmxE [12]. The amino acid predicted specific for
the A domain of PlpD was 2,4-diaminobutyric acid (Dab)
(Table 1). The presence of a starter C domain in PlpD, and
the specificity of the module for Dab are both consistent
with this module providing the first amino acid of the pel-
gipeptin peptide, and therefore the fatty acid side chain
should be connected to the peptide at this residue [13].
PlpE, containing 23 domains (A-T-C-A-T-C-A-T-E-C-A-
T-C-A-T-C-A-T-E-C-A-T-C), comprises seven modules
and a C-domain. The substrate specificities of the seven
PlpE A domains were predicted to activate the amino
acids Ile, Dab, Phe, Leu, Dab, Val, and Leu, respectively.
Two modules contain an epimerisation domain, indicating
that the related activated amino acids (Phe and Val) may
be converted into the D-configuration. Three domains (A-
T-TE) were present in PlpF, and the predicted amino acid
specific for the A domain was Ser. The last domain of thisTable 1 Predicted amino acids of adenylation domains in
the Plp synthetase
A-domain Amino acid at PheA residuea Predicted
substrate235 236 239 278 299 301 322 330 331 517
PlpD A1 D V G E I S A I D K Dab
PlpE A1 D G F F L G V V F K Ile
PlpE A2 D V G E I S A I D K Dab
PlpE A3 D A W T I A A I C K Phe
PlpE A4 D A W I I G A I V K Leu
PlpE A5 D V G E I S A I D K Dab
PlpE A6 D A F W I G G T F K Val
PlpE A7 D A W I I G A I V K Leu
PlpF A1 D V W H F S L V D K Ser
aThe residues were numbered according to the corresponding residues of
PheA.megasynthase was a thioesterase domain, indicating that
PlpF may be required for the release and cyclisation of the
synthesised lipopeptides. These results indicate that plpD
is the first and plpF the last gene involved in pelgipeptin
biosynthesis. Thus, the number of A domains, order of
modules for amino acid assembly, and location of epimeri-
sation domains perfectly correspond to the structural
characteristics of pelgipeptin (Figure 1), suggesting that
the plp gene cluster may be responsible for the synthesis
of pelgipeptin in the B69 strain.
In vitro assay of adenylation domains
The substrate specificity of four A domains, PlpD A1,
PlpE A1, PlpE A3, and PlpF A1 were determined
through a non-radioactive assay to link further the plp
gene cluster to pelgipeptin synthesis. The reason for our
selection of PlpD A1, PlpE A3, and PlpF A1 was that
their predicted products (Dab, Phe, and Ser, respectively)
were characteristic amino acids of pelgipeptin. The pre-
dicted product of Plp E A1 was Ile, but the correspond-
ing amino acid (position 2) in pelgipeptin was variable
(Ile or Val). This is the reason for our selection of PlpE
A1. Recombinant A-domain proteins were expressed
and purified as described in the “Materials and methods”
section above. All proteins with satisfactory yield (about
10 mg/L of culture) and purity (>95%) were obtained in
soluble form. The substrate selectivity of A domains was
determined with the 20 proteinogenic amino acids plus
L-Dab and D-Phe (Figure 2). PlpD A1, PlpE A3, and Plp
F A1 clearly exhibited the highest activity for L-Dab,
L-Phe, and L-Ser, respectively. PlpE A1 protein, however,
was found to activate L-Val (100%), L-Leu (82%), and
L-Ile (52%, the highest activity was set at 100%; back-
ground was usually below 5%). Val or Ile is found in dif-
ferent analogues of pelgipeptins at position 2
(Figure 1A), whereas no analogue with Leu at this pos-
ition was detected. This phenomena may be explained
by the effect of the C domain of module 2 (Figure 1), be-
cause in some cases, C domains also play an important
role in substrate selectivity [4,14]. In general, the four
tested recombinant A domains were found to activate
selectively predicted amino acids, experimentally con-
firming the speculation that the plp gene cluster
involved in pelgipeptin biosynthesis.
The plpA gene responsible for L-2,4-diaminobutyrate
biosynthesis
The peptide core of pelgipeptin contains three non-
proteinogenic amino acid L-2,4-diaminobutyrate at posi-
tions 1, 3, and 6. Several studies have indicated that this un-
usual amino acid is formed from aspartate β-semialdehyde
catalysed by the enzyme diaminobutyrate-2-oxoglutarate
transaminase [15,16]. The plpA gene encoded a putative
homologue of this enzyme and was proposed to be
Figure 2 Substrate specificity of the A domains by non-radioactive assay. The assay was performed with 20 different proteogenic amino
acids plus L-Dab and D-Phe. The highest activity was set at 100%. Only amino acids related to the composition of pelgipeptin are shown. Other
amino acids with relative activities < 5% are not shown.
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elgii B69. The deduced amino acid sequence of the plpA
gene product (PlpA, 428 amino acids) showed 50% and
38% identity with EctB from Halobacillus dabanensis [15]
and PvdH from Pseudomonas aeruginosa [16], respectively.
It has been demonstrated that an important substrate of
diaminobutyrate-2-oxoglutarate transaminase was aspartate
β-semialdehyde, which was formed from aspartyl phosphate
catalysed by aspartate-semialdehyde dehydrogenase [16].
Aspartate β-semialdehyde is also a metabolic precursor for
several other amino acids, including lysine, threonine, iso-
leucine, methionine, and diaminopimelate. Therefore, the
addition of these amino acids to the culture may be
favourable to the strain for the synthesis of pelgipeptin, al-
though most of these amino acids are not components of
this lipopeptide antibiotic. This hypothesis is supported by
a finding that the supplementation of a fermentation
medium with amino acids listed above increased the pro-
duction of pelgipeptin [3].The plpB gene encoded a predicted extracellular lipolytic
enzyme
The deduced product of plpB gene was a putative lipase/
esterase with a typical secretory signal peptide, contain-
ing three distinct domains, namely, an N domain with
two positively charged lysine, a hydrophobic core do-
main (H domain), and a C domain with the consensussequence A-X-A at positions 23 to 25, which was a type
I SPase cleavage site [17]. Cleavage at this site would
give rise to a predicted mature protein (PlpB) with 495
amino acids and a molecular mass of 53.8 kDa. A com-
parison of the deduced amino acid sequence of PlpB
with the sequence of lipase/esterase in the EMBL and
SwissProt databases showed significant homology to the
nucleophilic serine region of lipase/esterase, with 36%
identity to LipB from Bacillus subtilis [18,19]. LipB pre-
ferentially hydrolysed carboxyl esters of fatty acids with
short chain lengths (less than 10 carbon atoms), indicat-
ing that it was an esterase rather than a lipase. Similar to
the extracellular lipolytic enzymes from the related
genus Bacillus, Ala replaces the first Gly of the con-
served Gly-X-Ser-X-Gly pentapeptide motif in PlpB [20].
Previous studies have reported that supplementing the
fermentation medium with fatty acids of various chain
lengths enhanced the biosynthesis of lipopeptides con-
taining specific fatty acid side chains [21,22]. Thus, we
speculated that the predicted extracellular lipase, PlpB,
may facilitate the production of pelgipeptin through hy-
drolysis of water-soluble carboxyl esters in cultures of
strain B69.
The plpC gene encoded a predicted phosphopantetheinyl
transferase
The T domains of the PlpD-F must be converted from
their inactive apo forms to cofactor-bearing holo forms
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phopantetheinylation of thiotemplates. The product of
the plpC gene might be responsible for this conversion.
The deduced protein (244 amino acids) encoded by plpC
showed high similarity to Sfp from B. subtilis (38% iden-
tity, 58% similarity), Gsp from B. brevis (37% identity,
54% similarity), Psf-1 from B. pumilus (35% identity,
55% similarity), and other phosphopantetheinyl trans-
ferases associated with non-ribosomal peptide synthe-
tases. Further analysis indicated that PlpC fell within the
W/KEA subfamily of Sfp-like phosphopantetheinyl
transferases, which is involved in many kinds of second-
ary metabolite synthesis [23].
The N-terminal C domain
The plp gene cluster contained a special C domain at the
N terminus of PlpD (first C domain), in addition to eight
typical C domains that presumably catalyzed peptide-
bond formation between the adjacent amino acid resi-
dues of pelgipeptin. Sequence alignments shown that this
first C domain of PlpD had only 19-25% identity with the
remaining eight C domains of PlpD, -E, and –F, but
shared 31-43% identity with other first C domains of
lipopeptide synthetases, such as NRPSs of surfactin [24],
lichenysin [25], fengycin [26], fusaricidin [27] and poly-
myxin [12]. In the initiation reaction of the biosynthesis
of surfactin, module 1 of SrfA alone was sufficient to
catalyze the transfer of β-hydroxymyristoyl group to SrfA
followed by formation of β-hydroxymyristoyl-glutamate
[28]. The recent study of Choi’ group also suggested that
only the N-terminal C domain of PmxE was necessary
for the fatty acyl tailing of polymyxin [12]. Thus, in the
initial step of pelgipeptin biosynthesis, the PlpD N-
terminal C domain was proposed to catalyze the conden-
sation of the first amino acid (Dab) with a β-hydroxy
fatty acid transferred from coenzyme A.
Conclusions
In the present study, we identified a potential pelgipep-
tin synthetase gene cluster (plp) in P. elgii B69 through
genome analysis. The cluster spans 40.8 kb with three
NRPS genes (plpD, plpE, and plpF). The determination
of substrate specificity of four A domains, PlpD A1, PlpE
A1, PlpE A3, and Plp F A1 further linked the plp gene
cluster to pelgipeptin synthesis. We failed to provide a
final proof, which could have been obtained by con-
structing a pelgipeptin-deficient mutant, after numerous
attempts because this strain was hardly amicable to gen-
etic manipulation. However, all the results mentioned
above well supported the assignment of the plp gene
cluster as the one responsible for the production of pel-
gipeptin. Our results enrich the understanding of the en-
zymatic action in lipopeptide biosynthesis and provide
insight into the mechanism of natural product diversity.Competing interests
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